November 22, 2013
Japanese sales of Diovan (valsartan), an angiotensin receptor blocker (ARB) reeling from a clinical data manipulation scandal, dwindled 15.7% year on year to 22,033 million yen in July-September, according to NHI price-based data released by IMS Japan on November 19...read more